Zynerba Pharmaceuticals Inc
Save
–
Market cap
–
Current P/E
–
Forward P/E
About
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery.
Similar securities
Based on sector and market capitalization
Report issue